Status:
RECRUITING
Identification of Biomarkers for Patients with Vascular Anomalies
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
Lymphangiomatosis and Gorham's Disease Alliance (LGDA)
Klippel Trenaunay (KT) Support Group
Conditions:
Vascular Anomaly
Generalized Lymphatic Anomaly
Eligibility:
All Genders
1+ years
Brief Summary
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also...
Detailed Description
While vascular anomalies are rare diseases, they can be life-threatening and devastating to affected children and their families. Advances in diagnosis, monitoring and therapies will be significantly ...
Eligibility Criteria
Inclusion Criteria:
- Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
- All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.
Exclusion Criteria:
- N/A
Key Trial Info
Start Date :
April 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2050
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03001180
Start Date
April 1 2015
End Date
December 1 2050
Last Update
November 6 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
2
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229